lathosterol has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gylling, H; Hakkarainen, A; Hallikainen, M; Kotronen, A; Lundbom, N; Makkonen, J; Miettinen, TA; Sevastianova, K; Simonen, P; Yki-Järvinen, H | 1 |
| Athias, A; Beacco, M; Bouillet, B; Brindisi, MC; Cercueil, JP; Duvillard, L; Guiu, B; Hillon, P; Petit, JM; Rollot, F; Verges, B | 1 |
2 other study(ies) available for lathosterol and Liver Steatosis
| Article | Year |
|---|---|
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.
Topics: Adult; Aged; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Fatty Liver; Female; Humans; Insulin; Intestinal Absorption; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Sitosterols; Young Adult | 2011 |
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes.
Topics: Aged; Biomarkers; Cholesterol; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Phytosterols; Risk Factors; Sitosterols; Treatment Outcome | 2012 |